Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure.

Havranek, E P

Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. [electronic resource] - Journal of the American College of Cardiology Apr 1999 - 1174-81 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0735-1097

10.1016/s0735-1097(98)00695-0 doi


Adolescent
Adult
Angiotensin Receptor Antagonists
Antihypertensive Agents--administration & dosage
Biphenyl Compounds--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Heart Failure--blood
Hemodynamics--drug effects
Humans
Irbesartan
Male
Middle Aged
Norepinephrine--blood
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Safety
Single-Blind Method
Tetrazoles--administration & dosage
Treatment Outcome